Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating MicroRNAs, the Next-Generation Serum Biomarkers in Testicular Germ Cell Tumours: A Systematic Review
Ricardo Leão, Maarten Albersen, Leendert H. J. Looijenga, et al.
European Urology (2021) Vol. 80, Iss. 4, pp. 456-466
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

European Association of Urology Guidelines on Testicular Cancer: 2023 Update
Anna Patrikidou, Walter Cazzaniga, Daniel M. Berney, et al.
European Urology (2023) Vol. 84, Iss. 3, pp. 289-301
Closed Access | Times Cited: 130
Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
Jan Oldenburg, Daniel M. Berney, Carsten Bokemeyer, et al.
Annals of Oncology (2022) Vol. 33, Iss. 4, pp. 362-375
Open Access | Times Cited: 129
miRNAs orchestration of testicular germ cell tumors – Particular emphasis on diagnosis, progression and drug resistance
Ahmed E. Elesawy, Ahmed I. Abulsoud, Hebatallah Ahmed Mohamed Moustafa, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154612-154612
Closed Access | Times Cited: 32
Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study
Gazanfer Belge, Cansu Dumlupinar, Tim Nestler, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 2, pp. 404-412
Open Access | Times Cited: 17
Prognostic Factors for Relapse in Patients With Clinical Stage I Testicular Seminoma: A Nationwide, Population-Based Cohort Study
Thomas Wagner, Birgitte Grønkær Toft, Jakob Lauritsen, et al.
Journal of Clinical Oncology (2023) Vol. 42, Iss. 1, pp. 81-89
Closed Access | Times Cited: 16
The Value of Tumour Markers in the Detection of Relapse—Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study
Stefanie Fischer, Christian Rothermundt, Odile Stalder, et al.
European Urology Open Science (2023) Vol. 50, pp. 57-60
Open Access | Times Cited: 14
Prognostic factors for relapse in patients with clinical stage I testicular non-seminoma: A nationwide, population-based cohort study
Thomas Wagner, Birgitte Grønkær Toft, Jakob Lauritsen, et al.
European Journal of Cancer (2024) Vol. 202, pp. 114025-114025
Open Access | Times Cited: 5
Comparison of serum and plasma microRNA expression levels in patients with germ cell tumours
Fady Baky, Richard S. Matulewicz, Andrea Knežević, et al.
BJU International (2025)
Closed Access
Potentialities and critical issues of liquid biopsy in clinical practice: An umbrella review
Nicola Veronese, Claudio Luchini, Stefano Ciriminna, et al.
Translational Oncology (2025) Vol. 52, pp. 102172-102172
Closed Access
Biomarker microRNA-371a-3p - expression in malignancies other than germ-cell tumours
Gazanfer Belge, Markus Klemke, Bendix Hansen, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 2
Open Access
Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ cell tumors
Richard S. Matulewicz, Fady Baky, Nicole Liso, et al.
Annals of Oncology (2025)
Closed Access
MicroRNA‐371–373 cluster and methylome analysis suggests that a subset of ‘somatic‐type’ malignancies arising in germ cell tumors may originate in yolk sac tumor components
João Lobo, Nuno Tiago Tavares, Diana Fonseca, et al.
The Journal of Pathology (2025)
Open Access
Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours
Jan Roška, João Lobo, Danica Ivovič, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2495-2495
Open Access | Times Cited: 12
Circulating microRNAs as diagnostic biomarkers for melanoma: a systematic review and meta-analysis
Nan Wu, Hongyan Sun, Qian Sun, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Serum Levels of MicroRNA-371a-3p for Predicting the Histology of Postchemotherapy Residual Masses of Germ Cell Tumours
Klaus‐Peter Dieckmann, Francesca Grobelny, Armin Soave, et al.
European Urology Focus (2024) Vol. 10, Iss. 5, pp. 851-857
Closed Access | Times Cited: 4
A comprehensive overview of liquid biopsy applications in pediatric solid tumors
Ferdinand W. Janssen, Nathalie S.M. Lak, Claudia Y. Janda, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Combining Hypermethylated RASSF1A Detection Using ddPCR with miR-371a-3p Testing: An Improved Panel of Liquid Biopsy Biomarkers for Testicular Germ Cell Tumor Patients
João Lobo, Lieke M. J. van Zogchel, Mohammed Gussmalla Nuru, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5228-5228
Open Access | Times Cited: 25
DigiMir Test: Establishing a Novel Pipeline for MiR-371a Quantification Using Droplet Digital PCR in Liquid Biopsies From Testicular Germ Cell Tumor Patients
José Pedro Sequeira, João Lobo, Vera Constâncio, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 18
Male Infertility and the Risk of Developing Testicular Cancer: A Critical Contemporary Literature Review
Giuseppe Maiolino, Esaú Fernández‐Pascual, Mario Alberto Ochoa Arvizo, et al.
Medicina (2023) Vol. 59, Iss. 7, pp. 1305-1305
Open Access | Times Cited: 10
The Role of TP53 in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors
Dennis M. Timmerman, Thomas F. Eleveld, Ad Gillis, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11774-11774
Open Access | Times Cited: 21
Plasma miR‐21 as a potential predictor in prediabetic individuals with a positive family history of type 2 diabetes mellitus
Zakieh Yazdanpanah, Nasrin Kazemipour, Seyed Mehdi Kalantar, et al.
Physiological Reports (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 14
Children's Oncology Group's 2023 blueprint for research: Germ cell tumors
Roma Bhuta, Rachana Shah, Joanna J. Gell, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. S6
Open Access | Times Cited: 8
The Role of miRNA in Testicular Cancer: Current Insights and Future Perspectives
Francesco Ditonno, Antonio Franco, Celeste Manfredi, et al.
Medicina (2023) Vol. 59, Iss. 11, pp. 2033-2033
Open Access | Times Cited: 8
Circulating Biomarkers for Therapeutic Monitoring of Anti-cancer Agents
Helena J. Janse van Rensburg, Pavlina Spiliopoulou, Lillian L. Siu
The Oncologist (2022) Vol. 27, Iss. 5, pp. 352-362
Open Access | Times Cited: 13
Analytical Validation and Performance Characteristics of Molecular Serum Biomarkers, miR-371a-3p and miR-372-3p, for Male Germ Cell Tumors, in a Clinical Laboratory Setting
Fei Ye, Darren R. Feldman, Alisa Valentino, et al.
Journal of Molecular Diagnostics (2022) Vol. 24, Iss. 8, pp. 867-877
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top